On March 27, 2025, Mexico’s Federal Commission for the Protection Against Sanitary Risks (COFEPRIS) published an agreement in the Official Gazette of the Federation (DOF) outlining simplification measures for COFEPRIS procedures.
This week—Fri. Apr. 25: Understanding the Basics of PA Ag Exemptions for Inheritance Tax and Other Real Estate Transfers
National Agricultural Policy: USDA Cancels ‘Partnerships for Climate-Smart Commodities,’ Announces ‘Advancing Markets for Producers’
On April 14, 2025, the U.S. Department of Agriculture announced that the agency is cancelling its Partnerships for Climate-Smart Commodities (PCSC)
The California legislature continues to advance Senate Bill 601 (SB 601), the “Right to Clean Water Act,”[1] which aims to safeguard protections for California’s streams and wetlands that lost federal protection under the Clean Water Act (CWA) as a result of the Supreme Court’s 2023 Sackett v. U.S. EPA decision. If approved, SB 601 would expand enforcement to include citizen suits and increase penalties for unpermitted discharges to state waters.
The Coalition focuses on reducing regulatory burden in supply chain requirements, achieving net zero by 2045, and voluntary measures in environmental and resource management.
By Axel Schiemann, Stefan Bartz, Joachim Grittmann, and Falko Schmidt
Following the German federal election in February 2025, the new coalition consisting of CDU/CSU and SPD (the Coalition)
Several years ago, many of us were stunned to learn how much funding would run through FEMA’s BRIC program (Building Resilient Infrastructure and Communities). Traditionally, significant money only ran through the U.S. Army Corps of Engineers’ Civil Works Program. Big funds from FEMA tended to show up only after a disaster. But BRIC was going to change
National Energy Policy: Bureau of Land Management Rescinds Environmental Impact Statement Requirement
On April 11, 2025, the Bureau of Land Management (BLM) rescinded its notice which had required seven states to prepare an environmental impact statement (EIS) for various oil and gas operations. The seven states affected are Colorado, Montana, New Mexico, North Dakota, South
On Wednesday, April 16, Secretary of the Interior Doug Burgum directed the Bureau of Ocean Energy Management (BOEM) to order Equinor to “stop work” on its 812 megawatt Empire Wind 1 project just outside of New York Harbor. This project is a major component of New York’s plan to meet its 2040 carbon zero goal, and received all of its federal approvals in 2023 and 2024 after more than four years of intensive federal, state, and local environmental review. Equinor began active construction almost immediately after receiving full permitting approval in early 2024 and resumed marine activities in Spring 2025.
On April 17, the U.S. Fish and Wildlife Service (FWS) and National Marine Fisheries Service (NMFS) (together Services) published a proposed rule to rescind the long-standing definition of “harm” under the Endangered Species Act (ESA). The proposal appears to be one of the first in response to President Trump’s April 9 Presidential Memorandum, “Directing the Repeal of Unlawful Regulations,” which directs federal agencies to revise or rescind regulations that conflict with the plain meaning of the underlying statute. If adopted, it will significantly change the ESA’s implementation. The FWS and NMFS are taking comments on the proposed rule from April 17 through May 17.
The scheme’s expansion to include the steel, cement, and aluminum smelting industries increases the program’s coverage to 60% of China’s total greenhouse gas emissions.
By Paul A. Davies, JP Brisson, Michael Green, and Qingyi Pan
On March 26, 2025, China’s Ministry of Ecology and Environment (the MEE) published the “Work Plan for
On Monday, March 31, a court in the Eastern District of Texas found unlawful and vacated the Food and Drug Administration’s 2024 Rule regulating as “devices” under the Food, Drug, and Cosmetic Act FDCA, certain laboratory-developed tests used to diagnose, monitor, or determine treatment for diseases and conditions. The decision, American Clinical Laboratory Assoc. v. FDA